Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cellular translation machinery refers to the ensemble of molecular components responsible for synthesizing proteins from mRNA templates within cells. The core of this machinery is the ribosome, a complex of ribosomal RNA and proteins that catalyzes peptide bond formation. In addition to ribosomes, the machinery requires transfer RNAs (tRNAs) for amino acid delivery, multiple translation factors for initiation, elongation, and termination, and mRNAs as templates. The process is highly regulated and essential for gene expression, cell growth, response to environmental cues, and adaptation. Many antibiotics and some therapeutics function by targeting specific components of the translation machinery; however, broadly targeting this system often poses challenges due to its central role in vital cellular functions[1][3][4][5][6][7][9].
Inhibition of peptide bond formation (ribosome inhibitors); Disruption of ribosome function or assembly; Inhibition of translation initiation or elongation factors; Premature termination of translation.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cellular translation machinery.